Department of Systems Immunology, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Nat Commun. 2023 Mar 16;14(1):1462. doi: 10.1038/s41467-023-37205-5.
Protection from viral infections depends on immunoglobulin isotype switching, which endows antibodies with effector functions. Here, we find that the protein kinase DYRK1A is essential for B cell-mediated protection from viral infection and effective vaccination through regulation of class switch recombination (CSR). Dyrk1a-deficient B cells are impaired in CSR activity in vivo and in vitro. Phosphoproteomic screens and kinase-activity assays identify MSH6, a DNA mismatch repair protein, as a direct substrate for DYRK1A, and deletion of a single phosphorylation site impaired CSR. After CSR and germinal center (GC) seeding, DYRK1A is required for attenuation of B cell proliferation. These findings demonstrate DYRK1A-mediated biological mechanisms of B cell immune responses that may be used for therapeutic manipulation in antibody-mediated autoimmunity.
针对病毒感染的保护依赖于免疫球蛋白同种型转换,这使抗体具有效应功能。在这里,我们发现蛋白激酶 DYRK1A 通过调节类别转换重组 (CSR) 对 B 细胞介导的病毒感染和有效疫苗接种至关重要。缺乏 Dyrk1a 的 B 细胞在体内和体外的 CSR 活性受损。磷酸蛋白质组学筛选和激酶活性测定将 DNA 错配修复蛋白 MSH6 鉴定为 DYRK1A 的直接底物,并且单个磷酸化位点的缺失会损害 CSR。在 CSR 和生发中心 (GC) 接种后,DYRK1A 对于抑制 B 细胞增殖是必需的。这些发现表明 DYRK1A 介导的 B 细胞免疫反应的生物学机制可用于抗体介导的自身免疫中的治疗性操作。